Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genotype-specific neutralization and protection by antibodies against dengue virus type 3.

Journal of virology - 1 Oct 2010

Brien James D, Austin S Kyle, Sukupolvi-Petty Soila, O'Brien Katie M, Johnson Syd, Fremont Daved H, Diamond Michael S

Abstract excerpt

Dengue viruses (DENV) comprise a family of related positive-strand RNA viruses that infect up to 100 million people annually. Currently, there is no approved vaccine or therapy to prevent infection or diminish disease severity. Protection against DENV is associated with the development of neutralizing antibodies that recognize the viral envelope (E) protein. Here, with the goal of identifying monoclonal...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Neutralizing
Share to Antigenic Variation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cross Reactions

Share to Dengue

Share to Dengue Virus

Share to Epitope Mapping

Share to Immunization, Passive

Share to Viral Vaccines

Source

Open in PubMed Open full text

Identifiers

PMID: 20702644
DOI: 10.1128/JVI.01190-10
PMCID: PMC2950583

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genotype-specific neutralization and protection by antibodies against dengue virus type 3.PMID 20702644Read ↗

Natural strain variation and antibody neutralization of dengue serotype 3 viruses.Semantic proximity Read ↗

Structure and Function Analysis of Therapeutic Monoclonal Antibodies against Dengue Virus Type 2Semantic proximity Read ↗

The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1.Semantic proximity Read ↗

Development and characterization of a reverse genetic system for studying dengue virus serotype 3 strain variation and neutralization.Semantic proximity Read ↗

Characterization of Dengue Virus Complex-Specific Neutralizing Epitopes on Envelope Protein Domain III of Dengue 2 VirusSemantic proximity Read ↗

Type- and Subcomplex-Specific Neutralizing Antibodies against Domain III of Dengue Virus Type 2 Envelope Protein Recognize Adjacent EpitopesSemantic proximity Read ↗

A broadly neutralizing germline-like human monoclonal antibody against dengue virus envelope domain IIISemantic proximity Read ↗

The mechanism of differential neutralization of dengue serotype 3 strains by monoclonal antibody 8A1.Semantic proximity Read ↗

Antibody recognition and neutralization determinants on domains I and II of West Nile Virus envelope protein.Semantic proximity Read ↗

Mouse and Human Monoclonal Antibodies Protect against Infection by Multiple Genotypes of Japanese Encephalitis Virus.Semantic proximity Read ↗

Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions.Semantic proximity Read ↗

Variable Surface Epitopes in the Crystal Structure of Dengue Virus Type 3 Envelope GlycoproteinSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.